December 19, 2014
Novocure Announces Optune Now Available at more than 150 Leading Cancer Centers across the United States
December 18, 2014
Novocure to Present at the 33rd Annual J.P. Morgan Healthcare Conference
December 2, 2014
Novocure Announces FDA Approval of an IDE Supplement Allowing All Control Patients in its Phase III Trial in Newly Diagnosed GBM to Cross Over to Receive Tumor Treating Fields
December 1, 2014
Interim Analysis of Novocure’s Phase III Trial in Newly Diagnosed Glioblastoma to be Presented at Japan Society For Neuro-Oncology 2014
November 15, 2014
Novocure Announces the EF-14 Phase III Clinical Trial of Tumor Treating Fields in Patients with Newly Diagnosed Glioblastoma has been Terminated at the Interim Analysis due to Early Success
November 11, 2014
Novocure Announces the Presentation of New Data at the 19th Annual Society of Neuro-Oncology Meeting
October 30, 2014
